Cargando…
B7-Positive and B7-Negative Acute Myeloid Leukemias Display Distinct T Cell Maturation Profiles, Immune Checkpoint Receptor Expression, and European Leukemia Net Risk Profiles
Acute myeloid leukemia (AML) is generally considered a poorly immunogenic malignancy, displaying a “non-inflamed” leukemia microenvironment (LME), leading to T cell tolerance. However, the immune landscape of AML is much more heterogeneous. Since B7 expression is regarded as a consequence of an inte...
Autores principales: | Antohe, Ion, Dǎscǎlescu, Angela, Dǎnǎilǎ, Cǎtǎlin, Titieanu, Amalia, Zlei, Mihaela, Ivanov, Iuliu, Sireteanu, Adriana, Pavel, Mariana, Cianga, Petru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7082324/ https://www.ncbi.nlm.nih.gov/pubmed/32231996 http://dx.doi.org/10.3389/fonc.2020.00264 |
Ejemplares similares
-
A very rare case of FLT3-D835 positive blastic plasmacytoid dendritic cell neoplasm
por: Cianga, Vlad Andrei, et al.
Publicado: (2021) -
Combined flow cytometry natural killer immunophenotyping and KIR/HLA-C genotyping reveal remarkable differences in acute myeloid leukemia patients, but suggest an overall impairment of the natural killer response
por: Cianga, Vlad Andrei, et al.
Publicado: (2023) -
Let’s Talk About BiTEs and Other Drugs in the Real-Life Setting for B-Cell Acute Lymphoblastic Leukemia
por: Deak, Dalma, et al.
Publicado: (2019) -
Prognostic Value of Association of Copy Number Alterations and Cell-Surface Expression Markers in Newly Diagnosed Multiple Myeloma Patients
por: Dragoș, Mihaiela L., et al.
Publicado: (2022) -
Expression and prognosis of the B7 family in acute myeloid leukemia
por: Zhang, Wei, et al.
Publicado: (2021)